Open | $121.850 |
Close | $121.440 |
Volume / Avg. | 8.312M / 8.689M |
Day Range | 121.125 - 122.510 |
52 Wk Range | 99.140 - 130.240 |
Market Cap | $307.969B |
P/E Ratio | 868.000 |
Dividend Yield | 2.530% |
Exchange | NYSE |
RSI | 40 |
Short Interest | 0.66% |
Days to Cover | 2.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), CymaBay Therapeutics (NASDAQ:CBAY), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Merck & Co (NYSE: MRK) was reported by Societe Generale on Monday, March 11, 2024. The analyst firm set a price target for 104.00 expecting MRK to fall to within 12 months (a possible -14.47% downside). 36 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $121.6 last updated March 18, 2024 at 6:41 PM EDT.
A quarterly cash dividend of $0.77 per share of Class A Common Stock. The quarterly cash dividend was payable on April 5, 2024 to stockholders of record on March 14, 2024.
Merck & Co’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.